News
Uzbekistan develops a universal system of drug reimbursement
CIS Summit in Avaz: key decisions and social agenda
Kazakhstan is working on a mechanism for cross-country procurement of drugs
🧬 Novartis reaches $7.8 billion deal for mRNA therapy for autoimmune diseases
Russia was the first to decide on Itvisma funding for SMA
Kazakhstan summed up the first results of drug procurement reform: saving 70 billion tenge and new mechanisms for orphan drugs
The Ministry of Finance proposed to clarify the procedure for financing the "Circle of Good"
EU strengthens patients' role in evaluating new medical technologies
UK published SMA patient data used in Spinraza and Evrysdi reassessment
First EU gene therapy joint assessment: clinical effect confirmed, but Ireland does not recommend reimbursement at reported price
BRICS Delhi Declaration enshrines new areas of cooperation in healthcare
Conference "Real clinical practice. Possible and real"
China changes approach to access and financing of innovative drugs
Russia expanded the list of rare orphan diseases for the fourth time in 2026
Brazil Evaluates Multiple Technologies for PNH Treatment: An Example of an Integrated Approach to HTA
Russia is expanding its neonatal screening program for rare diseases.
Two child deaths have cast doubt on China's accelerated gene therapy research.
Первая терапия атаксии Фридрейха столкнулась с отказами в возмещении
Saudi Arabia is introducing a new accelerated route for orphan drugs.
FDA Proposes to Reduce Regulatory Burden in the Development of Platform-Based Gene Therapy Using Genome Editing
Patient Organisations in Europe Submit Comments on the First Joint Clinical Assessment Report under the HTA Regulation